Lymphoma Prognosis
New lymphoma prognosis research has been reported by scientists at Charles University, Faculty of Medicine
Published in Blood Weekly, July 9th, 2009
A new study, 'FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value,' is now available. "As positron emission tomography (PET) seems to be a powerful prognostic marker in the treatment of Hodgkin's lymphoma (HL), we analysed the prognostic value of PET after four cycles of combination therapy with bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone (BEACOPP) in patients with advanced-stage HL. From January 2004 to March 2007, 50 patients with newly diagnosed HL in clinical stages IIB with large mediastinal mass or extranodal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2009-07-09)
More Articles from Blood Weekly
- Acute Myelogenous Leukemia
Studies from University of Pittsburgh update current data on acute myelogenous leukemia - Antibiotics
Studies from P.I. Rafailidis et al add new findings in the area of antibiotics - BloodCenter of Wisconsin
BloodCenter of Wisconsin’s New Genetic Test Identifies People at High Risk for Developing Inherited Form of Leukemia - Cancer
Research from National Cancer Institute has provided new data on cancer - Cancer
Studies from A.A. Morales et al have provided new data on cancer - Chorioamnionitis
Data on chorioamnionitis detailed by researchers at Maastricht University - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
